plasmenylserine has been researched along with 1-aminocyclopentane-1,3,4-tricarboxylic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amori, L; Costantino, G; Flor, PJ; Gasparini, F; Kuhn, R; Marinozzi, M; Pellicciari, R; Vranesic, I | 1 |
| Acher, F; Bertrand, HO; Brabet, I; Pin, JP; Triballeau, N | 1 |
2 other study(ies) available for plasmenylserine and 1-aminocyclopentane-1,3,4-tricarboxylic acid
| Article | Year |
|---|---|
Synthesis, molecular modeling and preliminary biological evaluation of 1-amino-3-phosphono-3-cyclopentene-1-carboxylic acid and 1-amino-3-phosphono-2-cyclopentene-1-carboxylic acid, two novel agonists of metabotropic glutamate receptors of group III.
Topics: Animals; Biological Assay; CHO Cells; Colforsin; Cricetinae; Cyclopentanes; Excitatory Amino Acid Agonists; Humans; Molecular Structure; Receptors, Metabotropic Glutamate | 2000 |
Virtual screening workflow development guided by the "receiver operating characteristic" curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4.
Topics: Binding Sites; Databases, Factual; Drug Design; Models, Molecular; Quantitative Structure-Activity Relationship; Receptors, Metabotropic Glutamate; ROC Curve | 2005 |